APA

Hickok J. T., Roscoe J. A., Morrow G. R., Stern R. M., Yang B., Flynn P. J., Hynes H. E., Kirshner J. J. & Rosenbluth R. J. (19990715). Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. : Cancer.

Chicago

Hickok J T, Roscoe J A, Morrow G R, Stern R M, Yang B, Flynn P J, Hynes H E, Kirshner J J and Rosenbluth R J. 19990715. Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. : Cancer.

Harvard

Hickok J. T., Roscoe J. A., Morrow G. R., Stern R. M., Yang B., Flynn P. J., Hynes H. E., Kirshner J. J. and Rosenbluth R. J. (19990715). Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. : Cancer.

MLA

Hickok J T, Roscoe J A, Morrow G R, Stern R M, Yang B, Flynn P J, Hynes H E, Kirshner J J and Rosenbluth R J. Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. : Cancer. 19990715.